- Home
- CHEC vs MIST Comparison
CHEC vs MIST Comparison
Compare CHEC & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$0.81
Company Overview
Basic Information| Metric | CHEC | MIST |
|---|---|---|
| Founded | 2024 | 2003 |
| Country | Singapore | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.5M | 146.9M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CHEC | MIST |
|---|---|---|
| Price | $10.30 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 8.7K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $0.75 |
| 52 Week High | $10.56 | $3.06 |
Technical Indicators
Market Signals| Indicator | CHEC | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 73.84 | 29.06 |
| Support Level | $10.22 | N/A |
| Resistance Level | $10.47 | $1.42 |
| Average True Range (ATR) | 0.01 | 0.06 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 100.00 | 18.27 |
Price Performance
Historical Comparison CHEC
MIST
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.